<DOC>
	<DOCNO>NCT01348906</DOCNO>
	<brief_summary>This study aim determine effect intermittent normoxic cardiopulmonary bypass ( CPB ) inflammatory response , oxidative stress myocardial reperfusion injury adult patient undergo valve replacement . The investigator hypothesize nuclear factor kappa B ( NFkB ) involve regulate gene expression myocardial inflammatory factor .</brief_summary>
	<brief_title>Intermittent Normoxia Reduces Myocardial Reperfusion Injury</brief_title>
	<detailed_description>Methods : Patients meet requirement randomize 2 group : control group receive hyperoxic reperfusion ( PaO2 180-250 mmHg ) throughout CPB routine ; treatment group undergo 3 cycle 5/5 min normal/high oxygenation ( PaO2 80-150/180-250 mmHg ) cardioplegia arrest , maintain hyperoxia control group rest time CPB . The clinical data inotropes requirement , drainage , ventilation intensive care time record . Venous blood sample take perioperatively detect concentration troponin I ( cTnI ) , tumor necrosis factor-α , interleukin-6 , 10 , malondialdehyde ( MDA ) . Atrial biopsy remove cardioplegia arrest 30min aortic de-clamping determine extent neutrophil infiltration ( myeloperoxidase activity ) , NFkB bind DNA activity , gene expression inflammatory factor ( TNF-α , IL-6 , 10 ) . Statistical analysis : A sample size least 32 patient group need power 90 % , significance two-side 5 % level , basis SD 0.2 ng/ml difference peak serum cTnI release 0.15 ng/ml control condition patient determine . Expected Results : The treatment group significantly low release cTnI , inflammatory factor , MDA CPB afterwards . Intermittent normoxia may relate less myocardial inflammation characterize decreased myeloperoxidase activity , gene expression inflammatory factor , later may result reduce activity NFkB binding DNA reperfusion .</detailed_description>
	<mesh_term>Reperfusion Injury</mesh_term>
	<mesh_term>Hyperoxia</mesh_term>
	<mesh_term>Myocardial Reperfusion Injury</mesh_term>
	<criteria>rheumatic heart valve disease require selective aortic double valve ( aortic mitral valve ) replacement infective endocarditis congenital valve disease previous cardiac surgery complicate diabetes , coronary artery disease , hypertension peripheral vascular disease . receive aspirin , corticosteroid , angiotensinconverting enzyme inhibitor statin perioperatively</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2011</verification_date>
	<keyword>cardiopulmonary bypass</keyword>
</DOC>